# Fisetin to Reduce Senescence and Mobility Impairment in PAD

> **NCT06399809** · PHASE2 · RECRUITING · sponsor: **Northwestern University** · enrollment: 34 (estimated)

## Conditions studied

- Peripheral Arterial Disease
- Aging
- Peripheral Vascular Diseases
- Walking, Difficulty
- Claudication

## Interventions

- **DRUG:** Fisetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06399809
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-11
- **Final completion:** 2027-06
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06399809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06399809, "Fisetin to Reduce Senescence and Mobility Impairment in PAD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06399809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*